Compare, Analyse Biocon with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs ADCOCK INGRAM (S. Africa) - Comparison Results

BIOCON      Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 BIOCON    ADCOCK INGRAM
EQUITY SHARE DATA
    BIOCON
Mar-19
ADCOCK INGRAM
Jun-14
BIOCON /
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs707376-   
Low Rs554271-   
Sales per share (Unadj.) Rs91.9111.7-  
Earnings per share (Unadj.) Rs16.7-28.1-  
Cash flow per share (Unadj.) Rs24.2-23.3-  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs101.687.7-  
Shares outstanding (eoy) m600.00168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.92.9 237.1%   
Avg P/E ratio x37.7-11.5 -328.6%  
P/CF ratio (eoy) x26.1-13.9 -188.3%  
Price / Book Value ratio x6.23.7 168.3%  
Dividend payout %6.00-   
Avg Mkt Cap Rs m378,33054,555 693.5%   
No. of employees `0006.14.3 142.8%   
Total wages/salary Rs m11,6533,424 340.3%   
Avg. sales/employee Rs Th8,994.34,392.1 204.8%   
Avg. wages/employee Rs Th1,900.7797.6 238.3%   
Avg. net profit/employee Rs Th1,635.3-1,106.7 -147.8%   
INCOME DATA
Net Sales Rs m55,14418,855 292.5%  
Other income Rs m1,444132 1,093.6%   
Total revenues Rs m56,58818,987 298.0%   
Gross profit Rs m15,883-3,267 -486.1%  
Depreciation Rs m4,478814 550.3%   
Interest Rs m709511 138.8%   
Profit before tax Rs m12,140-4,460 -272.2%   
Minority Interest Rs m9-12 -72.4%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,123279 761.8%   
Profit after tax Rs m10,026-4,751 -211.0%  
Gross profit margin %28.8-17.3 -166.2%  
Effective tax rate %17.5-6.2 -279.9%   
Net profit margin %18.2-25.2 -72.2%  
BALANCE SHEET DATA
Current assets Rs m48,22813,810 349.2%   
Current liabilities Rs m30,3767,770 390.9%   
Net working cap to sales %32.432.0 101.1%  
Current ratio x1.61.8 89.3%  
Inventory Days Days68111 61.6%  
Debtors Days Days86124 69.0%  
Net fixed assets Rs m64,1308,050 796.7%   
Share capital Rs m3,00088 3,426.9%   
"Free" reserves Rs m57,9800-   
Net worth Rs m60,98014,799 412.0%   
Long term debt Rs m15,7665,201 303.2%   
Total assets Rs m121,92427,957 436.1%  
Interest coverage x18.1-7.7 -234.4%   
Debt to equity ratio x0.30.4 73.6%  
Sales to assets ratio x0.50.7 67.1%   
Return on assets %8.8-15.2 -58.0%  
Return on equity %16.4-32.1 -51.2%  
Return on capital %16.8-19.8 -84.6%  
Exports to sales %28.10-   
Imports to sales %18.90-   
Net fx Rs m5,1070-   
CASH FLOW
From Operations Rs m11,5461,609 717.4%  
From Investments Rs m-7,138-494 1,444.4%  
From Financial Activity Rs m-2,4174,720 -51.2%  
Net Cashflow Rs m2,1035,835 36.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.18 Rs / ZAR

Compare BIOCON With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare BIOCON With: WYETH  SHASUN PHARMA  NEULAND LABS  TORRENT PHARMA  ALEMBIC  



Today's Market

Sensex Ends 257 Points Higher; Tata Steel & Hindalco Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views On News

BIOCON Announces Quarterly Results (3QFY21); Net Profit Down 19.7% (Quarterly Result Update)

Jan 25, 2021 | Updated on Jan 25, 2021

For the quarter ended December 2020, BIOCON has posted a net profit of Rs 2 bn (down 19.7% YoY). Sales on the other hand came in at Rs 19 bn (up 5.9% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY21); Net Profit Down 23.9% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, BIOCON has posted a net profit of Rs 2 bn (down 23.9% YoY). Sales on the other hand came in at Rs 17 bn (up 11.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away? (Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

This Fund Manager Has Taken the World by Storm. Will You Invest With Her? (Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

FREE Event: Discover Your First Stock for a Potential Rs 7 Crore in Long-term Wealth
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

BIOCON SHARE PRICE


May 7, 2021 (Close)

TRACK BIOCON

MORE ON BIOCON

BIOCON 8-QTR ANALYSIS

COMPARE BIOCON WITH

FEATURED VIDEOS

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

More Featured Videos

MARKET STATS